Oramed Pharmaceuticals Inc. will be added to the Russell 2000 and Russell 3000 indexes following the 2026 Russell indexes semi-annual reconstitution, effective June 29, 2026. This inclusion reflects Oramed's ranking among the 4,000 largest U.S. stocks by market capitalization as of April 30, 2026. Being part of these indexes increases Oramed's visibility to institutional and retail investors who use Russell indexes as benchmarks and for index funds. This move may attract more investment and trading activity in Oramed shares.
UBS Group AG has notified Bang & Olufsen A/S that its shareholding and voting rights have dropped below the 5% threshold, holding 4.85% as of July 8, 2026. This update is in accordance with the Danish Capital Markets Act, which requires disclosure wh...
Assassin’s Creed Black Flag Resynced, a remake of the 2013 original, sold 2 million copies on its first day, marking a strong launch for Ubisoft. The game achieved the highest concurrent player count ever for the franchise on Steam and topped Twitch ...
VKNG Digital, founded by marketing expert Dave Anderson, has launched to provide high-quality SEO and PPC strategies to small and medium-sized businesses in Lancashire. The agency aims to bridge the gap where smaller businesses often lack access to e...
Strive, a Nasdaq-listed company holding nearly 20,000 Bitcoin on a debt-free balance sheet, is open to selling Bitcoin if it benefits shareholders but aims to remain a net buyer overall. CEO Matt Cole emphasizes outperforming Bitcoin itself rather th...
Apple has filed a lawsuit against OpenAI accusing it of stealing trade secrets and breaching contracts. The complaint alleges that OpenAI’s senior leadership, including Chief Hardware Officer Tang Tan, orchestrated the theft by recruiting Apple emplo...
